Ampio enters into collaborative research agreements to explore additional clinical indications for Ampion

Ampio enters into collaborative research agreements to explore additional clinical indications for Ampion

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug,... Read More

Monday December 14, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, FDA, COVID-19

Ampio's Phase I study for inhaled Ampion advances to completing enrollment of COVID-19 patients

Ampio's Phase I study for inhaled Ampion advances to completing enrollment of COVID-19 patients

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced its AP-014 Phase I inhaled Ampion clinical study in COVID-19 patients is proceeding to full open enrollment following... Read More

Friday December 4, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Michael Macaluso, COVID-19, Inhaled Ampion

DISH secures fiber for 5G network, signs agreements with 4 fiber vendors

DISH secures fiber for 5G network, signs agreements with 4 fiber vendors

ENGLEWOOD -- DISH announced it has signed agreements with four fiber vendors, Everstream, Segra, Uniti and Zayo, giving DISH fronthaul and backhaul support to connect its 5G network to sites... Read More

Thursday December 3, 2020 0 comments Tags: Englewood, Dish Network, Jeff McSchooler, Zayo, Steve Smith

Paragon 28 launches Silverback Posterior Plating System

Paragon 28 launches Silverback Posterior Plating System

ENGLEWOOD -- Paragon 28 announced another addition to its hindfoot fusion portfolio in 2020 with the launch of the Silverback Posterior Plating System. Paragon said the Silverback Ankle Fusion... Read More

Friday November 20, 2020 0 comments Tags: Englewood, Paragon 28, Silverback Posterior Plating System, Albert DaCosta

Ampio's Phase I study for Inhaled Ampion advances to 2nd group of COVID-19 patients with lung distress

Ampio's Phase I study for Inhaled Ampion advances to 2nd group of COVID-19 patients with lung distress

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced the second group in the Phase I inhaled Ampionclinical study is being treated following clearance by the Safety Monitoring... Read More

Wednesday November 11, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Inhaled Ampion, Michael Macaluso, COVID-19

Ampio begins Phase 1 clinical trial of inhaled Ampion for COVID-19

Ampio begins Phase 1 clinical trial of inhaled Ampion for COVID-19

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it hasbegun recruiting and enrolling patients in a Phase Imulti-center, randomized, controlled trial for a total of 40... Read More

Thursday October 29, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19, Michael Macaluso

Zynex appoints Neil Friery president and COO of Monitoring Solutions

Zynex appoints Neil Friery president and COO of Monitoring Solutions

ENGLEWOOD -- Zynex, Inc. (NASDAQ: ZYXI) today announced it hired Neil Friery as president and chief operating officer of its Monitoring Solutions Division. As president and COO, Friery will lead... Read More

Monday October 26, 2020 0 comments Tags: Englewood, Zynex, Neil Friery, Thomas Sandgaard

CSG joins Innovation Corridor accelerator to help global development of smart cities

CSG joins Innovation Corridor accelerator to help global development of smart cities

ENGLEWOOD -- CSG (NASDAQ: CSGS) announced it has joined the Innovation Corridor, a global technology and innovation accelerator. With this move, CSG said it will work with Innovation Corridor... Read More

Friday October 16, 2020 0 comments Tags: Englewood, CSG, Innovation Corridor, Alfred Binford, Eric Drummond